Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Nanoscope Therapeutics initiates rolling submission of BLA to FDA for MCO-010
3 Things You Should Know About Interventional Glaucoma Comanagement
Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Navigate successful cataract surgery with refractive technology
LIGHTHOUSE study of ATSN-201 expanded to continuous phase 1/2/3 trial following FDA feedback